Adagene Announces Progress and Expansion of Clinical Collaboration Program for Masked, Anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with KEYTRUDA® (pembrolizumab) to Demonstrate Further Efficacy in Patients with Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)

3M ago

ADAG

PremiumPress Releases

Adagene Presents Interim Results Reinforcing Best-in-Class Profile of Masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)

3M ago

ADAG

PremiumPress Releases

Adagene To Present Interim Results of Masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in MSS CRC at ASCO-GI Symposium

4M ago

ADAG

More ADAG News >

978 News on the Web

2024-03-29

Adagene Inc. Strikes Deal to Sell Depositary Shares

TipRanks News

Neutral

2024-03-29

Adagene’s Breakthroughs Promise Future Growth

TipRanks News

Neutral

2024-03-07

Adagene Appoints Heinz-Josef Lenz, M.D., FACP to Scientific and Strategic Advisory Board

Yahoo Finance

Neutral

2024-02-27

Adagene to Present at the Leerink Partners Global Biopharma Conference 2024

Yahoo Finance

Neutral

2024-02-09

Adagene Announces Progress and Expansion of Clinical Collaboration Program for Masked, Anti-CTLA-4 SAFEbody® ADG126

Yahoo Finance

Neutral

2024-01-25

Should You Buy Adagene Inc (ADAG) Stock After it Has Risen 24.63% in a Week?

Investors Observer

Neutral

2024-01-20

Week in Review: Lee’s Pharma Signs $138 Million Agreement For China Rights To Heart Failure Therapy

TalkMarkets

Neutral

2024-01-19

Healthcare Stocks Moving Friday: EWTX, PTN, TNYA, ALVO, AXDX, ADAG, CING, NKTX

Investors Observer

Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

Currently, no data available

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:978’s Media Buzz Sentiment?

Currently, no data Available

What is DE:978’s weekly average amount of articles?

Currently, no data Available

What is DE:978’s News Sentiment?

Currently, no data Available

Healthcare Stocks that are Trending in the News

DAWNDay One Biopharmaceuticals

IMVTImmunovant

HSTMHealthStream

RVVRevive Therapeutics

NVSNovartis

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing